Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company’s work with PRIMA is part of its path toward a novel brain-computer interface (BCI).

Hear why Science Corp CEO Max Hodak says the screen era is ending at TechCrunch Disrupt 2026

At this year’s Disrupt, Science Corp CEO Max Hodak will present a vision for screen-free interfaces that can even offer medical help. Register before September 25 to save up to $200 on your pass.